Study: Better Diagnostics Don’t Improve Antibiotic Prescription for MRSA

Using rapid molecular diagnostic testing for multidrug-resistant bacteria among patients with purulent skin infections did not reduce inappropriate antibiotic prescription of MRSA antibiotics for patients without an infection caused by the pathogen, according to research in Clinical Infectious Diseases.

Advertisement

The study followed 165 patients, 47 of whom tested positive for MRSA.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Researchers determined from a model that rapid diagnostic testing should have decreased inappropriate MRSA antibiotic prescription from 58 percent to 6.5 percent, though rates only dropped to 45 percent in practice, according to the study.

More Articles on Infection Control & Clinical Quality:

Study: Infection May Speed Cognitive Decline in Older Adults

Daily Chlorhexidine Baths Reduce MRSA Rates in ICU

Standard Cleaning Methods Don’t Kill HPV on Medical Equipment

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.